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Structure of murine and human renal type II Na+-phosphate
cotransporter genes (Npt2 and NPT2)
Abstract
Na+-phosphate (Pi) cotransport across the renal brush border membrane is the rate limiting step in the
overall reabsorption of filtered Pi. Murine and human renal-specific cDNAs (NaPi-7 and NaPi-3,
respectively) related to this cotransporter activity (type II Na+-Pi cotransporter) have been cloned. We
now report the cloning and characterization of the corresponding mouse (Npt2) and human (NPT2)
genes. The genes were cloned by screening mouse genomic and human chromosome 5-specific libraries,
respectively. Both genes are approximately 16 kb and are comprised of 13 exons and 12 introns, the
junctions of which conform to donor and acceptor site consensus sequences. Putative CAAT and TATA
boxes are located, respectively, at positions -147 and -40 of the Npt2 gene and -143 and -51 of the NPT2
gene, relative to nucleotide 1 of the corresponding cDNAs. The translation initiation site is within exon
2 of both genes. The first 220 bp of the mouse and human promoter regions exhibit 72% identity. Two
transcription start sites (at positions -9 and - 10 with respect to nucleotide 1 of NaPi-7 cDNA) and two
polyadenylylation signals were identified in the Npt2 gene by primer extension, 5' and 3' rapid
amplification of cDNA ends (RACE). A 484-bp 5' flanking region of the Npt2 gene, comprising the
CAAT box, TATA box, and exon 1, was cloned upstream of a luciferase reporter gene; this construct
significantly stimulated luciferase gene expression, relative to controls, when transiently transfected into
OK cells, a renal cell line expressing type II Na+ -Pi cotransporter activity. The present data provide a
basis for detailed analysis of cis and trans elements involved in the regulation of Npt2/NPT2 gene
transcription and facilitate screening for mutations in the NPT2 gene in patients with autosomally
inherited disorders of renal Pi reabsorption.
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ABSTRACT Na+-phosphate (Pi) cotransport across the
renal brush border membrane is the rate limiting step in the
overall reabsorption of filtered Pi. Murine and human renal-
specific cDNAs (NaPi-7 and NaPi-3, respectively) related to this
cotransporter activity (type II Na+-Pi cotransporter) have been
cloned. We now report the cloning and characterization of the
corresponding mouse (Npt2) and human (NPT2) genes. The
genes were cloned by screening mouse genomic and human
chromosome 5-specific libraries, respectively. Both genes are
approximately 16 kb and are comprised of 13 exons and 12
introns, the junctions of which conform to donor and acceptor
site consensus sequences. Putative CAAT and TATA boxes are
located, respectively, at positions -147 and -40 of the Npt2 gene
and -143 and -51 of the NPT2 gene, relative to nucleotide 1 of
the corresponding cDNAs. The translation initiation site is
within exon 2 of both genes. The first 220 bp of the mouse and
human promoter regions exhibit 72% identity. Two transcription
start sites (at positions -9 and -10 with respect to nucleotide 1
of NaPi-7 cDNA) and two polyadenylylation signals were iden-
tified in the Npt2 gene by primer extension, 5' and 3' rapid
amplification ofcDNA ends (RACE).A 484-bp 5' flanking region
of the Npt2 gene, comprising the CAAT box, TATA box, and exon
1, was cloned upstream of a luciferase reporter gene; this
construct significantly stimulated luciferase gene expression,
relative to controls, when transiently transfected into OK cells,
a renal cell line expressing type II Na+-Pi cotransporter activity.
The present data provide a basis for detailed analysis of cis and
trans elements involved in the regulation of Npt2/NPT2 gene
transcription and facilitate screening for mutations in the NPT2
gene in patients with autosomally inherited disorders of renal Pi
reabsorption.
The mammalian kidney is an important arbiter of extracellular
phosphate (Pi) homeostasis. Renal Pi reabsorption occurs
predominantly in the proximal tubule where concentrative,
Na+-gradient dependent Pi transport across the brush border
membrane is the rate limiting step in the overall Pi reabsorp-
tive process and the site for its regulation (1-6). Although
parathyroid hormone and Pi availability are the most impor-
tant regulators of renal Na+-Pi cotransport, a variety of
hormones including thyroid hormone, 1,25-dihydroxyvitamin
D, insulin-like growth factor I, insulin, epidermal growth factor,
and glucocorticoids can also modulate cotransporter activity
(1-6). However, the molecular mechanisms involved in many of
these regulatory processes have not been clearly defined.
Several Mendelian disorders of Pi homeostasis can be attrib-
uted to a specific defect in renal Pi reabsorption (7, 8). Autosomal
and X-linked forms have been described and both are charac-
terized by reduced growth rate and hypophosphatemic bone
disease (7,8). The mutant genes responsible for the defect in renal
Pi transport in these conditions are unknown, with the exception
of a candidate gene (PEX) for X-linked hypophosphatemia,
recently identified by positional cloning (9).
The cloning of homologous cDNAs encoding high-affinity,
renal-specific type II Na+-Pi cotransporters from several mam-
malian species has provided structural information about the
molecular entities that mediate the cotransport process (10-13).
Injection of cloned cRNAs into Xenopus oocytes conferred
Na+-dependent Pi transport with kinetic parameters, Na+-Pi
stoichiometry, and pH dependence similar to that seen in isolated
renal brush border membrane vesicles (10-13). The cDNAs
encode glycosylated proteins of "70 kDa with eight putative
transmembrane domains (10-13) that have been localized by
immunohistochemistry to the apical surface of proximal tubular
cells (14).
The human type II Na+-Pi cotransporter gene (NPT2) was
mapped to human chromosome 5q35 by fluorescence in situ
hybridization (15), thereby ruling it out as a candidate gene for
X-linked hypophosphatemia, consistent with the positional clon-
ing of the PEX gene (9). Of interest, however, is the demonstra-
tion that in hypophosphatemic (Hyp) mice harboring the homol-
ogous X-linked mutation, decreased renal Pi reabsorption can be
ascribed to a decrease in brush border membrane Na+-Pi co-
transport that is associated with a proportional decrease in type II
Na+-Pi cotransporter mRNA and immunoreactive protein (16).
These findings suggest that the PEX gene product plays an
important role in the regulation of type II Na+-Pi cotransporter
gene expression. However, the mechanism for this regulation is not
understood.
The present study was undertaken to define the structure of the
murine (Npt2) and human (NPT2) type II Na+-Pi cotransporter
genes. Promoter sequences and intron/exon boundaries were
identified for both genes. Our results thus provide a basis for
future studies to characterize promoter activity, elucidate the
mechanisms underlying the regulation of Npt2/NPT2 gene ex-
pression, and screen for mutations in patients with Mendelian
hypophosphatemias that are autosomally inherited.
MATERIALS AND METHODS
Southern Blot Analysis ofMouse and Human DNA. Genomic
DNA from mouse liver and human peripheral blood leukocytes
was isolated by the phenol-chloroform method described by
Sambrook et al. (17). DNA (10 ,ug) was digested with restriction
endonucleases (5 units/,ug DNA) under conditions specified by
the supplier and electrophoresed on 0.8% agarose gels in 1 x
TAE buffer (0.04MTris acetate/0.001 M EDTA, pH 8.0). A 1-kb
DNA ladder (GIBCO/BRL) was run in parallel with the digested
DNA. DNA fragments were capillary transferred to nitrocellu-
Abbreviation: RACE, rapid amplification of cDNA ends.
Data deposition: The sequences reported in this paper have been
deposited in the GenBank database [accession nos. U56664-U56673,
U57491, and U57839 (for mouse) and U56674-U56695 and U57548
(for human)]
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FIG. 1. Organization of the mouse Npt2 gene. Genomic clones and subclones used for the analysis of Npt2 gene structure are indicated. The
restriction map of the Npt2 gene was derived by digestion of subcloned genomic fragments with EcoRI (E), HindIII (H), and SacI (S). The position
of introns (depicted by dotted vertical lines and numbered 1-12) was determined by sequencing across intron/exon boundaries of subcloned genomic
fragments and PCR products amplified from mouse genomic DNA, using exonic primers. Intron size was estimated by restriction analysis, by direct
sequencing for small introns, and by estimating the size ofPCR amplification products for large introns. Exons are depicted as filled boxes (numbered
I-XIII) and their size is indicated by the number above each box.
lose membranes [supported nitrocellulose BA-(S)85, Schleicher
& Schuell] or nylon membranes (Biodyne B transfer membrane;
Pall) with 20 x SSC as described elsewhere (17). Full-length
murine NaPi-7 (13) and human NaPi-3 (10) cDNAs were 32p_
labeled to a specific activity of >1 x 109 cpm/,g with [a-32p]
dCTP (3000 Ci/mmol; 1 Ci = 37 GBq; ICN) using a Radprime
DNA labeling kit (GIBCO/BRL). Hybridization was performed
at 42°C for 16-18 h in 10% dextran sulfate, 40% formamide, 4 x
SSC, 0.02 M Tris HCl (pH 7.6), 1 x Denhardt's solution and
herring sperm DNA (0.1 mg/ml). The membranes were washed
several times with 2 x SSC/0.1% SDS at room temperature and
with 0.1 x SSC/0.1% SDS at 65°C. Mouse DNA was digested
with EcoRI, HindIII, BglII, EcoRV, MluI, and human DNA with
EcoRI, HindIlI, MluI, EcoRV, KpnI, BamHI, and BamHI +
MluI.
Murine and Human Genomic DNA Library Screening. A A
DASH II mouse (129SV strain) genomic DNA library (received
from A. Karaplis, McGill University) was screened with a full-
length rat NaPi-2 cDNA probe (10). Two genomic clones, des-
ignated A 13.3 and A YC (Fig. 1), were isolated. Digestion of the
13.3-kb clone with EcoRI generated 2.1-, 7.7-, and 3.5-kb frag-
ments (designated pB 2.1, pB 7.7, and pB 3.5 in Fig. 1), which were
subcloned into pBluescript II (Stratagene). To clone the 5'
flanking region of theNpt2 gene, a A Gem 11 library derived from
mouse AB-1 embryonic stem cell DNA (a gift from U. Muller,
University of Zurich) was screened with a 5' fragment of the
NaPi-7 cDNA (545 bp derived by digestion with MluI and Sacl).
One of three positive clones, spanning 11 kb (A 11.0, in Fig. 1), was
digested with BamHI to yield a 6.0-kb fragment (pB 6.0, Fig. 1),
which was further digested with EcoRI. Two of 3 resulting
fragments, designated pB 1.5 (1.5-kb fragment) and pB 1.4
(1.4-kb fragment) (Fig. 1), were subcloned into pBluescript II. A
2.0-kb fragment (pB 2.0, Fig. 1), which overlapped with the
sequence of pB 1.5 and pB 1.4 (Fig. 1) was obtained by Hindlll
digestion of A 11.0 and was subcloned into pBluescript II. A
human chromosome 5-specific A library (American Type Culture
Collection) was screened with a full-length human cDNA
(NaPi-3) probe (10). One of four positive A clones was digested
with EcoRI and 3.8- and 4.2-kb fragments were subcloned into
pBluescript II.
Nucleotide Sequencing. Genomic Npt2 and NPT2 subclones
were sequenced using the Sequenase Version 2.0 kit (United
States Biochemical) with [a-35S]dATP (ICN). The 5' and 3'
RACE products were sequenced using a T7 Sequencing kit
(Pharmacia). DNA fragments, generated by PCR amplification
of mouse or human genomic DNA, were sequenced using the
double-stranded DNA cycle sequencing system (GIBCO/BRL).
Sequencing reactions were resolved on 8% polyacrylamide gels.
Sequencing primers were designed from the NaPi-7 (13) and
NaPi-3 (10) cDNA sequences.
PCR Amplification. PCR amplification of genomic clones or
genomic DNA was performed using forward and reverse primer
pairs based on the NaPi-7 and NaPi-3 cDNA sequences. The
amplification reactions contained 100-200 ng of DNA, 2.5 units
of Taq polymerase (GIBCO/BRL) or 1 unit of Elongase
(GIBCO/BRL), 10 ,ul of 10 x PCR buffer (GIBCO/BRL), 200
,uM dNTPs, 20 pmol ofeach primer, and 1-3mM MgCl2 in a total
volume of 100 ,ul. After an initial 1.5-min denaturation step at
94°C, 30-35 cycles of amplification were performed using a
Perkin-Elmer/Cetus DNA thermal cycler. After the last cycle,
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FIG. 2. Southern blot analysis of mouse genomic DNA. Mouse liver
DNA (10 gg) was digested with EcoRl, Hindlll, Bglll, or EcoRV,
electrophoresed on 0.8% agarose gels, transferred to supported ni-
trocellulose, and hybridized with a full-length 32p-labeled rat NaPi-2
cDNA probe (10). The size calibration was obtained by simultaneous
loading of a 1-kb DNA ladder.
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FIG. 3. Comparison of the Npt2 and NPT2 genes. Location of intron/exon boundaries was determined as described in the legend to Fig. 1 and
in Materials and Methods. Introns are depicted by triangles and are numbered 1-12. The size of each intron (bp) is shown above each triangle. Exons
are numbered I-XIII. Numbers below the line depict the location of introns in the corresponding NaPi-7 and NaPi-3 cDNAs. The vertical dashed
lines represent the 5' and 3' ends of the corresponding cDNAs.
elongation was extended to 7 min at 72°C. The primer-template
annealing temperatures were approximately 2°C below the Tm of
the oligonucleotide primers used. The size of PCR amplified
products was estimated by agarose (0.7-2.0%) gel electrophoresis
using 100 bp or 1 kb DNA ladders (GIBCO/BRL). PCR products
were sequenced as described above to confirm the identity of
products. In some cases, PCR amplification products were sub-
cloned into a pCRII vector using a TA cloning system, version 2.2(Invitrogen) and then sequenced as described above for subcloned
fragments.
Intron/Exon Mapping. The location of and sequences at
intron/exon boundaries of the Npt2 and NPT2 genes were
determined by sequencing of genomic subclones as described
above. To determine whether there are introns downstream from
nucleotide 1463 of the NaPi-7 cDNA or downstream from
nucleotide 1497 of the NaPi-3 cDNA, PCR amplification reac-
tions were performed with both Taq polymerase and Elongase
using five different forward and reverse primer pairs with mouse
genomic DNA, the mouse A YC clone (Fig. 1) or human genomic
DNA as template. Appropriate water blanks and PCR reactions
with cDNA templates were run simultaneously. The identity of
PCR products was confirmed by sequencing as described above.
RACE. For 5' RACE mouse kidney total RNA (10 ,ug) (18)
and poly(A)+ RNA (1 ,tg) [poly(A) Tract System 1000, Pro-
mega] were reverse transcribed using 20 units of MuLV reverse
transcriptase (Promega) with a NaPi-7-specific primer (nt 195-
210 of NaPi-7 cDNA; antisense). The 5' end of the cDNA was
extended with polynucleotide transferase (30 units, GIBCO/
BRL) in presence of 0.4 mM dATP. PCR was then performed
with a second NaPi-7-specific primer (nt 63-78 of NaPi-7 cDNA;
antisense), a hybrid dT17 adapter primer with a 5' extension
containing a SalI recognition site and an adapter primer corre-
sponding to the 5' extension of the dT17 adapter primer (19). A
second PCR reaction was performed with the adapter primer
mentioned above and a third NaPi-7-specific primer (nt 26-41 of
NaPi-7 cDNA; antisense). The products were treated with the
SureClone ligation kit (Pharmacia), digested with SalI (restriction
site located in the adapter primer), subcloned into pBluescript II,
and sequenced as described above. For 3' RACE mouse kidney
total RNA (10 uLg) and poly(A)+ RNA (1 ,ug) were prepared and
reverse transcribed using the dT17 adapter primer mentioned
above (19). PCR was performed with the adapter primer and a
NaPi-7-specific primer (nt 1544-1565 of NaPi-7 cDNA; sense).
The products were digested with PstI and Sall, subcloned into
pBluescript II, and sequenced.
Primer Extension. A NaPi-7-specific primer, localized within
the 5' untranslated region of the cDNA (nt 63-78; antisense), was
labeled with 8 units of polynucleotide kinase (Promega) and 50
ILCi of [y-32P]ATP. The labeled primer (-92,000 cpm) was
annealed to 5 tg of total RNA or 4 ,ug ofpoly(A)+ RNA, isolated
Table 1. Npt2/NPT2 gene intron/exon boundaries
Mouse
Intron Location Donor Acceptor
1 32 GTCAAG/gtgag tgcag/GACTCA
2 162 CACAAG/gtaaa ctcag/TCCTGC
3 312 AGCCAG/gtagg tccag/AGCCCA
4 441 CTGGAG/gtagg tgcag/GGAAGG
5 585 CCGGCT/gtgag accag/TGTTGG
6 697 CAGGCG/gtgag ctcag/GGCTTT
7 893 ATCCAG/gtgag cacag/CTGGAC
8 989 ACAGAG/gtgag tttag/GCTTCC
9 1053 AGAAAT/gtaag ttcag/GCAACC
10 1220 ACACAG/gtgag ttcag/ACTTTC
11 1338 TCATTG/gtgag accag/GCCTGG
12 1463 TTTCAG/gtaca ctgag/ATTGCC
Human
1 34 TCTAAG/gtgaa ttcag/CGTTGC
2 190 CTCAGG/gtaag cctag/TCCTAC
3 340 AGCCAG/gtggg tccag/AGTCCA
4 469 CTGGAG/gtagg cccag/GGAAGG
5 613 CTGGCT/gtgta accag/TGCTGG
6 725 CCGGCG/gtgtg cccag/GGCCTT
7 921 ATCCAG/gtgac cacag/CTGGAC
8 1017 TTACAG/gtgag tctag/GCTCCC
9 1087 AGAAAT/gtaag gcaag/GCAACC
10 1254 AATACG/gtgtg ttgag/GACTTC
11 1372 TCATCG/gtgag cccag/GTCTTG
12 1497 TTCCAG/gtgcg tgcag/ATTGCC
Location of introns and donor/acceptor site sequences for the Npt2
and NPT2 genes. The intron location is based on the nucleotide
number in the corresponding NaPi-7 and NaPi-3 cDNAs. Exon
sequences are depicted in uppercase letters and intron sequences in
lowercase letters.
Physiology: Hartmann et al.
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Table 2. Npt2/NPT2 gene exon/intron boundary codons
Mouse Human
Intron Codon phase Amino acid Codon phase Amino acid
2 I VAL I VAL
3 I GLU I GLU
4 I GLY I GLY
5 I LEU I LEU
6 II ARG II ARG
7 0 GLN 0 GLN
8 0 GLU 0 GLN
9 I CYS I CYS
10 I ASP 0 THR
11 I GLY I GLY
12 0 GLN 0 GLN
Amino acid and codon phase usage at exon/intron boundaries of the
Npt2 and NPT2 genes. The translational start site for both the mouse
and human genes lies within exon II (Fig. 3). Introns that do not split
codon triplets are indicated by phase 0, interruption after the first
nucleotide by phase I, and interruption after the second nucleotide by
phase II. Amino acids encoded at the splice sites are indicated.
from mouse kidney as described above. cDNA synthesis was
carried out with 20 units ofMuLV reverse transcriptase (Promega)
as recommended by the supplier. The products ofcDNA synthesis
were loaded on a 6% sequencing gel along with a sequencing
ladder prepared with the above primer and cDNA product.
Npt2 Promoter Analysis. A 484-bp Npt2 fragment was PCR-
amplified from the pB 1.5 subclone, using forward and reverse
primers corresponding to nucleotides -454 to -435 and 11-30 of
the Npt2 gene, respectively (see Fig. 4). The fragment was
subcloned into pBluescript II and the sequence confirmed. The
fragment was then excised and inserted immediately upstream of
a luciferase reporter gene in a promoterless luciferase expression
vector (pGL3-basic, Promega). Correct insertion was verified by
sequencing and the right orientation was designated pGL3-484.
OK cells that were 40-50% confluent and cultured on 3.5-cm
plates as described (20) were transfected with 0.15 ,g of the
pGL3-484 construct using Ca2PO4 (21). pCMV-lacZ (0.2 ,ug,
provided by S. Rusconi, University of Zurich) was cotransfected
with the reporter gene construct to control for transfection
efficiency. Additional controls were performed by mock-
transfection or by transfection with pGL3-basic (0.15 ,tg). The
mouse gene gacagtct.g
11
human gene gaagaacctg
mouse gene tcttgggggt
III 11111
human gene tctcaggggt
accataggct
1111111
accatagatt
aaagttaatt
1111111
gaggttaatt
mouse gene tcattaagga ctttgccctt
III 1111111111
human gene ---- caggga ctttgccctt
* *
mouse gene ----ctttag
11 11
human gene ggtcctggag
+1
acttccccaA
li1
gcttcattga
f3-galactosidase assay was done in 0.2 M NaPO4 (pH 7.5), 4
mg/ml O-nitrophenyl ,B-D-galactopyranoside, 1mM MgCl2 for 30
min at 37°C and the optical density measured at 420 nm.
Luciferase was assayed with a luciferase kit and measured in a
luminometer (Lumac Biocounter M1500, MBV, Stafa, Switzer-
land).
RESULTS AND DISCUSSION
Southern Blot Analysis ofMurine and Human Genomic DNA.
Southern blot analysis of murine (Fig. 2) and human (not shown)
genomic DNA, using full-length NaPi-7 and NaPi-3 cDNA
probes, was used to estimate the size and complexity of the Npt2
and NPT2 genes. Based on digests with at least five restriction
endonucleases, or combinations thereof, an approximate size of
16 kb was estimated for both the mouse and human genes. This
estimate is in good agreement with the size of the Npt2 and NPT2
genes determined from genomic cloning (see below). Blots
washed at both high -and low stringency gave similar results,
suggesting that the Npt2 and NPT2 genes are single copy genes
and not part of a larger subfamily of related genes.
Organization of the Npt2 and NPT2 Genes. Two overlapping
Npt2 clones (A 13.3 kb and 11.0 kb, Fig. 1) were isolated by
screening two mouse genomic DNA libraries. The 13.3-kb clone
contained nucleotides 33-1463 of the mouse NaPi-7 cDNA, a
portion of the 5' untranslated region, the ATG translation start
site (within exon II), and 12 intron/exon boundaries (Fig. 1). The
11-kb clone contained the first four exons and extended 9 kb into
the 5' flanking region of the gene. The Npt2 gene did not contain
introns downstream of nucleotide 1463 of the cDNA. This was
established by PCR ampliflcation of mouse genomic DNA with
five different primer pairs, using both Taq polymerase and
Elongase, which permits amplification of long, single-copy
genomic templates (up to 20 kb). In none of the reactions were
PCR products detected that exceeded the size expected for the
cDNA. The absence of PCR products in corresponding water
blanks indicated that contamination with cDNA could not ac-
count for our findings. These data were confirmed by PCR
amplification of the genomic clone A YC (Fig. 1).
A single genomic A clone obtained by screening a human
chromosome 5-specific library was digested with EcoRI and the
3.8- and 4.2-kb genomic fragments generated were subcloned.
The 3.8-kb fragment contained nucleotides 34-1017 of the
cDNA, a portion of the 5' untranslated region, the ATG trans-
ccccctgcag
li1 11111
ccccatgcag
aggtgaagat tagCAATtaa ctggaaggaa
11 III III III11111 1111 11111
agctgacgat tagCAATtaa ctgggaggaa
taatggggaa aagagggaag gcagctaaag
11111 1111111 1 1111111
...ggggga. cagagggagg gcagctaggg
gacccgaggg
11111 11
gacccaagag
GCAGCCGGGC
11 11 11
gCTGCTGAGC
+1
TATAAAgaag agggtcttag
11111111 1111111 11
TATAAAgagg agggtctcag
ttcttctagt
III
ttc
ttcct-----
III
ttctcctcag
TGGAGCTGAG CCACAG---
111111 11 11
AGAAGCTGAA ACACAG---
FIG. 4. Sequence comparison of the 5' flanking regions of the Npt2 and NPT2 genes. A comparison of the first 220 bp of the mouse and human
promoter sequences revealed an identity of 72%. CAAT and TATA boxes are depicted in boldface, uppercase letters. The transcription start sites
of the Npt2 gene are marked by asterisks. The nucleotides corresponding to the NaPi-7 and NaPi-3 cDNAs are given in uppercase letters. The first
nucleotide of each cDNA is labeled as + 1. Gaps in the corresponding sequences between the two genes are presented as a dashed line. The sequences
were compared and aligned using a program package (Genetics Computer Group, Version 8), which introduces gaps for best fit.
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FIG. 5. Determination of the transcriptional start site of the Npt2
gene by primer extension and 5' RACE. Mouse kidney poly(A)+ RNA(A) and total RNA (B) were hybridized with a 32P-labeled primer (nt
63-78 of NaPi-7 cDNA) and the primer extension products, generated
with reverse transcriptase, were run on 6% polyacrylamide gels. A
sequencing ladder prepared with the same primer and the mouse
cDNA products was also run on the gel. The extended products were
9 and 10 nucleotides upstream from nucleotide 1 of NaPi-7 cDNA. The
double band for total RNA is only visible with longer exposure time.
The asterisk depicts the start of the NaPi-7 cDNA sequence and is
followed by the sequence of the adaptor used for cloning the cDNA
into pSPORT. The boldface letters shown on the right are derived
from sequencing two 5' RACE products.
lation initiation site, and eight intron/exon boundaries of the
NPT2 gene. Four additional intron/exon boundaries in the NPT2
gene were identified by sequencing PCR products obtained by
amplification of human genomic DNA using primers designed
from NaPi-3 cDNA sequence. The absence of introns down-
stream from nucleotide 1497 of the cDNAwas confirmed byPCR
amplification as described above for the Npt2 gene.
A comparison of the Npt2 and NPT2 genes is depicted in Fig.
3. The number, relative position, and size of introns are similar for
both murine and human genes. Nucleotide sequences at the
intron/exon boundaries of both Npt2 and NPT2 genes conform
to the GT/AG rule for intron donor and acceptor splice sites(Table 1). The amino acids and codon phase usage at exon/intron
boundaries are also remarkably similar for both the murine and
6-
5-
.u
L_
4C
.Q
L
4-
3-
2-
1 -
T
MOC pGL3-basic pGL3-484
FIG. 7. Expression of a Npt2 promoter-luciferase construct in OK
cells. A 484-bp fragment of the Npt2 promoter region, comprising exon
I, TATA and CAAT boxes, and 5' sequence, was cloned upstream of
a luciferase reporter gene (pGL3-484) as described. OK cells at
40-50% confluency were cotransfected with pGL3-484 and pCMV-
lacZ to correct for transfection efficiency. Controls were performed
with mock-transfected OK cells and OK cells transfected with the
plasmid lacking the Npt2 promoter fragment (pGL3-basic). After 2
days, the OK cells were harvested and luciferase and 3-galactosidase
assayed. Luciferase activity was related to j3-galactosidase activity.
Normalized luciferase activity in OK cells transfected with pGL3-basic
was set at one. The data represent the mean ±SD derived from six
experiments.
human genes and differed only in two amino acids and one codon
phase usage (Table 2). In addition, a comparison of intronic
sequences (introns 2-4) in the Npt2 andNPT2 genes revealed 68%identity.
Structure of the 5' Flanking Region of the Npt2 and NPT2
Genes. Sequence analysis of the pB 1.5 subclone (Fig. 1) of the
Npt2 gene revealed a TATA box at position -40 and a CAAT
box at position -147, relative to the first nucleotide of NaPi-7
cDNA (Fig. 4). For the NPT2 gene, sequencing the 4.2-kb
genomic fragment (see above) revealed a TATA box at
position -51 and a CAAT box at position -143, relative to
nucleotide 1 of NaPi-3 cDNA (Fig. 4). A comparison of 220 bp
from the murine and human promoter regions is depicted in
Fig. 4 and shows an overall sequence identity of 72%.
2110 acctgtgcat attaagggcc acagtggcat gggcttttgt aattaagagg tagtgtgcac
* poly A tail (a)
2170 aaatacatgc taggtactga gcctgtgtga ccattagtgc gggtgtaatg tgagtacact
2230 gtgtgggtac aggggggtgc agatgcctag ggagtctcca aacttttctg gaaagagtca
2290 gctataccct ctcatcttct cacaactctt gtaccaacag gagggacaga agaacagctg
2350 gccttctgta tacatgggcc ttacttctgc caattctgct aactgtgcat agaaaaaaaa
* poly A tail (b)
2410 agttgaaagt tgc 2422
FIG. 6. 3' RACE of mouse kidney mRNA. Two 3' RACE products were obtained with reverse-transcribed mouse kidney poly(A)+ RNA and
total RNA as described. The depicted sequence is that of the 3' end and the numbering corresponds to that of NaPi-7 cDNA. Two poly(A) tails
were identified, at nucleotide 2189 (a) and 2422 (b), respectively. Both were preceded by a polyadenylylation signal (underlined).
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FIG. 8. Superimposition of the exon boundaries with the predicted secondary structure of the Npt2 protein. The secondary structure was derived
from a combination of hydropathy analysis and the inside positive rule. The shaded boxes represent the suggested eight transmembrane regions
(numbered M1-M8 in ref. 10). Triangles depict the positions of the exon/intron boundaries. Exons are numbered I-XIII.
Transcription Initiation and Polyadenylylation Sites in the
Npt2 Gene. The transcription initiation site for the mouse gene
was determined by primer extension and 5' RACE. In primer
extensions, reverse transcription of poly(A)+ RNA showed two
signals, at -9 and -10 (Fig. 5), i.e., 9 and 10 nucleotides upstream
from the first nucleotide of the NaPi-7 cDNA (Fig. 4). Similar
results were obtained by sequencing the 80-bp amplification
product derived from 5' RACE (Fig. 5).
The 3' region of the transcribed Npt2 gene was determined by
3' RACE. Products of 650 and 900 bp were obtained, subcloned,
and sequenced. The larger product ended with a poly(A) tail at
nucleotide 2422 and corresponded exactly to the NaPi-7 cDNA
(Fig. 6). The shorter 650 bp product was formed from an earlier
polyadenylylation signal derived from a cDNA of 2189 bp (Fig. 6).
These fmdings are consistent with the appearance and size of two
transcripts (2.6 and 2.4 kb) detected with a full-length, rat NaPi-2
cDNA probe on Northern blots of mouse kidney RNA (10).
Promoter Activity of the 5' Flanking Region of the Npt2 Gene.
We determined whether a 484 bp 5' fragment of the Npt2 gene,
containing part of exon I, the TATA and CAAT boxes, could
drive the expression of a luciferase reporter gene. The 484-bp
fragment functioned as a promoter of luciferase activity following
transfection of the pGL3-484 promoter-reporter construct in
OK cells (Fig. 7). Correction for transfection efficiency was
accomplished by cotransfecting OK cells with the pCMV-lacZ
vector. After normalization with respect to ,B-galactosidase ac-
tivity, luciferase activity was 5 times greater in OK cells trans-
fected with pGL3-484 than in cells transfected with the same
vector lacking the Npt2 promoter fragment (pGL3-basic) (Fig. 7).
Lack of Correlation Between Exon-Defined Peptide Domains
and Predicted Npt2 Secondary Structure. Fig. 8 shows the
superimposition of exon boundaries on the Npt2/NaPi-7 protein
secondary structure model, derived from a combination of hy-
dropathy analysis (22, 23) and the inside positive rule (24, 25).
Although previous reports showed that transcripts for several
membrane spanning transporter genes and other membrane
protein genes are frequently spliced near membrane/aqueous
transitions (see ref. 26), no such relationship was apparent with
Npt2. Moreover, in the case of the Npt2 gene, exon boundaries are
located within predicted transmembrane domains as well as in
intracellular and extracellular domains (Fig. 8). Similar findings
apply to NPT2.
Conclusions. This study describes the molecular cloning and
genomic organization ofNpt2 and NPT2, murine and human type
II Na+-Pi cotransporter genes. The membrane proteins they
encode are expressed exclusively in the brush border membrane
of renal proximal tubular cells where they mediate the rate
limiting step in the renal reabsorption of filtered Pi (1-6).
Npt2/NPT2 thus play a key role in the overall maintenance of
extracellular Pi homeostasis and are crucial for normal bone
mineralization and growth. Our data provide a basis for detailed
analysis of cis and trans elements involved in the regulation of
Npt2/NPT2 gene transcription and facilitate screening for mu-
tations in the NPT2 gene in patients with autosomally inherited
disorders of renal Pi reabsorption.
Note. In a recent abstract, Taketani et al. (27) reported that the human
renal type II Na+-phosphate cotransporter gene spans 8 kb and
consists of 10 exons. We have no explanation for the discrepany
between those findings and the results of this study.
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